Target intelligence / Profile preview

Dextrin

Molecular classification
Other
01

Overview

Dextrin refers to a heterogeneous group of low-molecular-weight carbohydrates, generally produced by the hydrolysis (breakdown) of starch or glycogen through enzymatic or thermal means. These molecules are composed of D-glucose units connected by α-(1→4) or α-(1→6) glycosidic bonds, forming oligo- or polysaccharide chains of varying lengths and branching patterns. Dextrins are not a single chemical entity but rather a class of compounds whose properties (such as solubility and digestibility) depend on chain length and branching[2][4][7][8]. In biological systems, dextrins are intermediates in the digestion of starches, facilitating glucose release. Some dextrins, such as resistant dextrin, function as dietary fiber and display prebiotic activity, helping modulate gut microbiota and potentially leading to metabolic health benefits (e.g., improved glucose control, increased short-chain fatty acid production, altered bile acid metabolism). These effects are general nutritional benefits, not targeted pharmacological actions[3][8]. Dextrins are recognized as safe for use in food and industrial contexts and are not direct targets for therapeutic drugs or biomarker assays[7][10].

Other names
DextrinsDextrineCaloreenDextridFortodexStarch gumα-D-GlucopyranoseTapioca dextrin
02

Biological functions

Dietary fibercarbohydrate intermediaryglucose sourceprebiotic effect
03

Disease associations

Other (dietary/prebiotic modulation; no direct disease “target” role)
04

Safety considerations

Low toxicity; usually recognized as safe in food use

Beyond the preview

Go deeper on Dextrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dextrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call